Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Urol Oncol. 2008 Jul 17;27(5):496–501. doi: 10.1016/j.urolonc.2008.05.004

Table 2.

Treatment-related toxicities and supplemental GU toxicities

N=45 Grade
1 (n) 2 (n) 3 (n)
General treatment-related toxicity type

Leukopenia 1 - -
Granulocytopenia 1 - -
Thrombocytopenia 1 - -
Anemia 5 - 1
Hemorrhage - 1 -
Infection 1 5 1
Fever(No Infection) 2 1 -
Nausea/vomiting 3 - -
Diarrhea 1 - -
Liver 3 - -
Skin 3 - -
Alopecia 1 - -
Weight Gain 1 - -
Weight Loss 1 - -
Abdominal cramps 1 - -
Edema 1 - -
Myalgia 1 - -
Fatigue 4 1 -
Chills 3 - -
Pain, other 1 - -

WORST DEGREE 18 7 2

Supplemental genitourinary toxicity type

Incontinence 2 2 1

Dysuria 7 7 3

Urinary retention 2 - -

Increased frequency/ urgency 9 11 2

Hemorrhagic cystitis - 1 -

Bladder cramps 1 3 -

Bladder-other 3 4 -

Renal failure - - -

Renal-other - - -

Ureteral obstruction - - -

GU fistula - - -

GU-other 3 2 1

WORST DEGREE 13 16 5